Tenet Healthcare (THC)
(Real Time Quote from BATS)
$93.15 USD
+2.07 (2.27%)
Updated Apr 19, 2024 03:47 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Tenet Healthcare (THC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$109.71 | $137.00 | $68.00 | 20.45% |
Price Target
Based on short-term price targets offered by 17 analysts, the average price target for Tenet Healthcare comes to $109.71. The forecasts range from a low of $68.00 to a high of $137.00. The average price target represents an increase of 20.45% from the last closing price of $91.08.
Analyst Price Targets (17)
Broker Rating
Tenet Healthcare currently has an average brokerage recommendation (ABR) of 1.18 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 17 brokerage firms. The current ABR compares to an ABR of 1.19 a month ago based on 16 recommendations.
Of the 17 recommendations deriving the current ABR, 15 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 88.24% and 5.88% of all recommendations. A month ago, Strong Buy made up 87.5%, while Buy represented 6.25%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 15 | 15 | 14 | 14 | 14 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.18 | 1.18 | 1.19 | 1.19 | 1.19 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/11/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Strong Buy | Strong Buy |
3/5/2024 | Cantor Fitzgerald & Co | Sarah James | Strong Buy | Strong Buy |
11/20/2023 | Truist Securities | David S Macdonald | Strong Buy | Strong Buy |
11/2/2023 | Raymond James | John W Ransom | Strong Buy | Strong Buy |
11/1/2023 | Stephens | Scott Fidel | Hold | Hold |
10/31/2023 | SVB Securities | Whit Mayo | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.18 |
ABR (Last week) | 1.18 |
# of Recs in ABR | 17 |
Average Target Price | $109.71 |
LT Growth Rate | 5.00% |
Industry | Medical - Hospital |
Industry Rank by ABR | 96 of 252 |
Current Quarter EPS Est: | 1.45 |